Urethral cancer staging: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
No edit summary |
||
(15 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Urethral cancer}} | {{Urethral cancer}} | ||
{{CMG}} | {{CMG}}; {{AE}}{{Vbe}} | ||
==Overview== | ==Overview== | ||
The staging of urethral cancer is based on the [[TNM]] staging system. | The [[Staging (pathology)|staging]] of urethral cancer is based on the [[TNM]] [[Cancer staging|staging]] system. | ||
==Staging== | ==Staging== | ||
'''Definitions of TNM''' <ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> | '''Definitions of TNM''' <ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> | ||
The American Joint Committee on Cancer has designated staging by TNM classification to define urethral cancer. | The [[American Academy of Allergy, Asthma, and Immunology|American]] Joint Committee on [[Cancer]] has designated staging by TNM [[classification]] to define [[urethral cancer]]. | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" | |||
| valign="top" | | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | |||
|valign=top| | |||
|+ | |+ | ||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|TNM}} | ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|TNM}} | ||
Line 49: | Line 44: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor invades other adjacent organs. | | style="padding: 5px 5px; background: #F5F5F5;" |Tumor invades other adjacent organs. | ||
|- | |- | ||
| style="padding: 5px 5px; font-size: 100%; background: #f0f0f0" | | colspan="3" style="padding: 5px 5px; font-size: 100%; background: #f0f0f0" |Urothelial (Transitional Cell) Carcinoma of the Prostate | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | | | style="padding: 5px 5px; background: #DCDCDC;" | | ||
Line 74: | Line 69: | ||
other adjacent organs. | other adjacent organs. | ||
|- | |- | ||
| style="padding: 0 5px; background: #4479BA" | | colspan="3" style="padding: 0 5px; background: #4479BA" |{{fontcolor|#FFF| Regional Lymph Nodes}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |NX | | style="padding: 5px 5px; background: #DCDCDC;" |NX | ||
Line 88: | Line 83: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Metastasis in a single node more than 2 cm in greatest dimension, or in multiple nodes. | | style="padding: 5px 5px; background: #F5F5F5;" |Metastasis in a single node more than 2 cm in greatest dimension, or in multiple nodes. | ||
|- | |- | ||
| style="padding: 0 5px; background: #4479BA" | | colspan="3" style="padding: 0 5px; background: #4479BA" |{{fontcolor|#FFF| Distant Metastasis}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |M0 | | style="padding: 5px 5px; background: #DCDCDC;" |M0 | ||
Line 95: | Line 90: | ||
| style="padding: 5px 5px; background: #DCDCDC;" |M1 | | style="padding: 5px 5px; background: #DCDCDC;" |M1 | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Distant metastasis. | | style="padding: 5px 5px; background: #F5F5F5;" |Distant metastasis. | ||
|- | |||
| colspan="3" style="padding: 5px 5px; font-size: 80%; background: #f0f0f0" |Urethra. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 508-9. | |||
|} | |||
'''Anatomic Stage''' | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" | |||
| valign="top" | | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stage}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| T}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| N}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| M}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |0a | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Ta | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" |0is | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Tis | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:Tis | |||
:pu | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:Tis | |||
:pd | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |I | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" |II | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T2 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" |III | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T2 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T3 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T3 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" |IV | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T4 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N0 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |T4 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N1 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Any T | |||
| style="padding: 5px 5px; background: #F5F5F5;" |N2 | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Any T | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Any N | |||
| style="padding: 5px 5px; background: #F5F5F5;" |M0 | |||
|- | |||
| colspan="4" style="padding: 5px 5px; font-size: 80%; background: #f0f0f0" |Urethra. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 508-9. | |||
|} | |} | ||
Line 103: | Line 179: | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Urologic Surgery]] | [[Category:Urologic Surgery]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Urology]] | |||
[[Category:Nephrology]] | |||
[[Category:Surgery]] |
Latest revision as of 15:47, 23 January 2019
Urethral cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Urethral cancer staging On the Web |
American Roentgen Ray Society Images of Urethral cancer staging |
Risk calculators and risk factors for Urethral cancer staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
The staging of urethral cancer is based on the TNM staging system.
Staging
Definitions of TNM [1]
The American Joint Committee on Cancer has designated staging by TNM classification to define urethral cancer.
TNM | Definition | |
---|---|---|
TX | Primary tumor cannot be assessed. | |
T0 | No evidence of primary tumor. | |
Ta | Noninvasive papillary, polypoid, or verrucous carcinoma. | |
Tis | Carcinoma in situ. | |
T0 | No evidence of primary tumor. | |
T1 | Tumor invades subepithelial connective tissue. | |
T2 | Tumor invades any of the following: corpus spongiosum, prostate, periurethral muscle. | |
T3 | Tumor invades any of the following: corpus cavernosum, beyond prostatic capsule, anterior vagina, bladder neck. | |
T4 | Tumor invades other adjacent organs. | |
Urothelial (Transitional Cell) Carcinoma of the Prostate | ||
|
Carcinoma in situ, involvement of the prostatic urethra. | |
|
Carcinoma in situ, involvement of the prostatic ducts. | |
T1 | Tumor invades urethral subepithelial connective tissue. | |
T2 | Tumor invades any of the following: prostatic stroma, corpus spongiosum, periurethral muscle. | |
T3 | Tumor invades any of the following: corpus cavernosum, beyond prostatic capsule, bladder neck (extraprostatic extension). | |
T4 | Tumor invades other adjacent organs (invasion of the bladder).
other adjacent organs. | |
Regional Lymph Nodes | ||
NX | Regional lymph nodes cannot be assessed. | |
N0 | No regional lymph node metastasis. | |
N1 | Metastasis in a single lymph node 2 cm or less in greatest dimension. | |
N2 | Metastasis in a single node more than 2 cm in greatest dimension, or in multiple nodes. | |
Distant Metastasis | ||
M0 | No distant metastasis. | |
M1 | Distant metastasis. | |
Urethra. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 508-9. |
Anatomic Stage
Stage | T | N | M |
---|---|---|---|
0a | Ta | N0 | M0 |
0is | Tis | N0 | M0 |
|
N0 | M0 | |
|
N0 | M0 | |
I | T1 | N0 | M0 |
II | T2 | N0 | M0 |
III | T1 | N1 | M0 |
T2 | N1 | M0 | |
T3 | N0 | M0 | |
T3 | N1 | M0 | |
IV | T4 | N0 | M0 |
T4 | N1 | M0 | |
Any T | N2 | M0 | |
Any T | Any N | M0 | |
Urethra. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 508-9. |
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq